IDXX Stock Recent News
IDXX LATEST HEADLINES
Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.
Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks presents investors with the better value opportunity right now?
IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.
Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business and momentum in ProCyte One expansion.
Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment.
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
Many investors are used to looking for sectors to make bets on. Technology.
Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance.
Given its better prospects, we believe that IDEXX Laboratories stock (NASDAQ: IDXX) is a better pick over Kimberly-Clark stock (NYSE: KMB).